What is NDC 0002-3115?

0002-3115 is the product NDC for galcanezumab-gnlm, Galcanezumab 100 mg/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 1 package NDC, shown above in 10- and 11-digit form.

Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for galcanezumab-gnlm?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

galcanezumab-gnlm NDC 0002-3115 | National Drug Code

Unfinished product

This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-3115Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-3115Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-3115-00	00002311500	1 mL in 1 SYRINGE (0002-3115-00)Marketed from 04-JUN-19

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Generic name (nonproprietary): galcanezumab-gnlm
Active ingredients: Galcanezumab — 100 mg/mL
Dosage form: Injection, Solution
Labeler: Eli Lilly and CompanyNDC labeler code 0002
Product type: Drug for further processing
Marketing category: Drug for further processing
Marketing start: Jun 4, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78fSPL ID 368df5d9-5eeb-49c7-a0dd-8a326ee5d78f

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400002311500 followed by a unit qualifier and the quantity

Package 00002-3115-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0002-3115

What is NDC 0002-3115?: 0002-3115 is the product NDC for galcanezumab-gnlm, Galcanezumab 100 mg/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: galcanezumab-gnlm.
What is the active ingredient?: Galcanezumab.
Who is the labeler?: Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for galcanezumab-gnlm?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.